These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 22427435)

  • 1. Atrial fibrillation and cardiac resynchronization therapy: how should rate be controlled?
    Rienstra M
    Eur J Heart Fail; 2012 Jun; 14(6):569-70. PubMed ID: 22427435
    [No Abstract]   [Full Text] [Related]  

  • 2. Atrioventricular Junction Ablation for Atrial Fibrillation.
    Patel D; Daoud EG
    Heart Fail Clin; 2016 Apr; 12(2):245-55. PubMed ID: 26968669
    [TBL] [Abstract][Full Text] [Related]  

  • 3. AV junction ablation in heart failure patients with atrial fibrillation treated with cardiac resynchronization therapy: the picture is now clear!
    Gasparini M; Galimberti P
    J Am Coll Cardiol; 2012 Feb; 59(8):727-9. PubMed ID: 22340264
    [No Abstract]   [Full Text] [Related]  

  • 4. Current role of atrioventricular junction (AVJ) ablation.
    Hoffmayer KS; Scheinman M
    Pacing Clin Electrophysiol; 2013 Feb; 36(2):257-65. PubMed ID: 23078186
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Meta-analysis of biventricular vs. right ventricular pacing mode in patients with atrial fibrillation undergoing atrioventricular nodal ablation: what was the quality of the included trials?
    Kwong JS; Cheuk-Man Y
    Eur J Heart Fail; 2012 Nov; 14(11):1311; author reply 1311-2. PubMed ID: 22927637
    [No Abstract]   [Full Text] [Related]  

  • 6. Cardiac resynchronization therapy in patients with permanent atrial fibrillation. Is it mandatory to ablate the atrioventricular junction to obtain a good response?
    Tolosana JM; Arnau AM; Madrid AH; Macias A; Lozano IF; Osca J; Quesada A; Toquero J; Francés RM; Bolao IG; Berruezo A; Sitges M; Alcalá MG; Brugada J; Mont L;
    Eur J Heart Fail; 2012 Jun; 14(6):635-41. PubMed ID: 22396459
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rhythm Control and AV Node Ablation in CRT Patients with Atrial Fibrillation: Should They be Performed Together or Alternatively?
    Ciszewski J; Sterlinski M
    Pacing Clin Electrophysiol; 2015 Jul; 38(7):906-7. PubMed ID: 25880466
    [No Abstract]   [Full Text] [Related]  

  • 8. Atrioventricular nodal ablation in heart failure: the picture is clear but incomplete.
    Lim S
    J Am Coll Cardiol; 2012 Oct; 60(16):1578-9. PubMed ID: 23058316
    [No Abstract]   [Full Text] [Related]  

  • 9. Response.
    Schwartzman D; Bazaz R; Jain S; Saba S; Gorcsan J; Adelstein E
    Pacing Clin Electrophysiol; 2015 Jul; 38(7):907. PubMed ID: 25880132
    [No Abstract]   [Full Text] [Related]  

  • 10. Role of Atrioventricular Junctional Ablation and Cardiac Resynchronization Therapy in Patients with Chronic Atrial Fibrillation.
    Steinberg JS
    Card Electrophysiol Clin; 2019 Mar; 11(1):147-154. PubMed ID: 30717847
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Device Therapy for Rate Control: Pacing, Resynchronisation and AV Node Ablation.
    Lau DH; Thiyagarajah A; Willems S; Rostock T; Linz D; Stiles MK; Kaye D; Kalman JM; Sanders P
    Heart Lung Circ; 2017 Sep; 26(9):934-940. PubMed ID: 28687248
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Atrial fibrillation and cardiac resynchronization therapy.
    Gasparini M; Galimberti P
    Curr Opin Cardiol; 2018 Jan; 33(1):1-6. PubMed ID: 29045344
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A pilot study to assess benefit of atrial rhythm control after cardiac resynchronization therapy and atrioventricular node ablation.
    Schwartzman D; Housel D; Bazaz R; Jain S; Saba S; Gorcsan J; Adelstein E
    Pacing Clin Electrophysiol; 2015 Feb; 38(2):275-81. PubMed ID: 25431023
    [TBL] [Abstract][Full Text] [Related]  

  • 14. How to Improve Cardiac Resynchronization Therapy Benefit in Atrial Fibrillation Patients: Pulmonary Vein Isolation (and Beyond).
    Gianni C; Di Biase L; Mohanty S; Gökoğlan Y; Güneş MF; Al-Ahmad A; Burkhardt JD; Natale A
    Heart Fail Clin; 2017 Jan; 13(1):199-208. PubMed ID: 27886924
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of cardiac resynchronization therapy and atrioventricular junction ablation in patients with permanent atrial fibrillation.
    Kaszala K; Ellenbogen KA
    Eur Heart J; 2011 Oct; 32(19):2344-6. PubMed ID: 21659440
    [No Abstract]   [Full Text] [Related]  

  • 16. Atrioventricular nodal ablation predicts survival benefit in patients with atrial fibrillation receiving cardiac resynchronization therapy.
    Dong K; Shen WK; Powell BD; Dong YX; Rea RF; Friedman PA; Hodge DO; Wiste HJ; Webster T; Hayes DL; Cha YM
    Heart Rhythm; 2010 Sep; 7(9):1240-5. PubMed ID: 20156595
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Should all patients undergoing atrioventricular junction ablation receive cardiac resynchronization therapy?
    Jensen-Urstad M
    Europace; 2012 Oct; 14(10):1383-4. PubMed ID: 22927666
    [No Abstract]   [Full Text] [Related]  

  • 18. Complete atrioventricular block DOES reduce mortality in patients with atrial fibrillation treated with cardiac resynchronization therapy.
    Gasparini M; Galimberti P; Leyva F
    Eur J Heart Fail; 2014 Jan; 16(1):114. PubMed ID: 24453102
    [No Abstract]   [Full Text] [Related]  

  • 19. Complete atrioventricular block does reduce mortality in patients with atrial fibrillation treated with cardiac resynchronization therapy: reply.
    Tolosana JM; Trucco E; Mont L
    Eur J Heart Fail; 2014 Jan; 16(1):115. PubMed ID: 24453103
    [No Abstract]   [Full Text] [Related]  

  • 20. A rare cause of ventricular fibrillation after atrioventricular node ablation: what is the mechanism?
    Stojadinović P; Peichl P; Wichterle D; Kautzner J
    Kardiol Pol; 2018; 76(6):1024. PubMed ID: 29905371
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.